Skip to main content

Table 4 Pathology and adjuvant treatment of patients who underwent conversion surgery

From: Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone conversion surgery

 

UPC

n = 63 a

LAPC

n = 49a

MPC

n = 14

Local tumor diameter (mm)

26.98

29.08

19.64

Number of dissected lymph nodes

12 (1–47)

12 (1–47)

11 (1–20)

Positivity of lymph nodes

26 (41)

22 (45)

4 (29)

Pathological response based on CAP grade

 0

4 (6)

1 (2)

3 (21)

 1

10 (16)

10 (20)

0 (0)

 2

41 (65)

33 (67)

8 (57)

 3

8 (13)

5 (10)

3 (21)

TNM classification (restage)

 0

3 (5)

1 (2)

2 (14)

 I

15 (24)

11 (22)

4 (28)

 II

19 (30)

19 (39)

0 (0)

 III

16 (25)

16 (33)

0 (0)

 IV

10 (16)

2 (4)

8 (57)

Adjuvant therapy

56 (89)

42 (86)

14 (100)

Adjuvant therapy regimen

 mFFX

38 (60)

27 (55)

11 (79)

 GnP

7 (11)

5 (10)

2 (14)

 Other

11 (17)

10 (20)

1 (7)

  1. aFour patients continued to have unresectable pancreatic cancer intraoperatively and were excluded
  2. CAP grade The College of American Pathologists (CAP) scoring system